TAKHZYRO lanadelumab (rch) 300mg/2mL solution for injection vial (302300)

ARTG ID 302300

ARTG Name

TAKHZYRO lanadelumab (rch) 300mg/2mL solution for injection vial

Product name

TAKHZYRO lanadelumab 300mg/2mL solution for injection vial

ARTG Date

30 January 2019

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

lanadelumab

Licence category

RE

Licence status

A

Summary

Product information

Related information

TAKHZYRO lanadelumab (rch) 300mg/2mL solution for injection vial (2023-24)

2023-24

Annual charge exemption

Exempt from annual charge in 2023-24 due to Takeda Pharmaceuticals Australia Pty Ltd declaring $0 turnover in that period.
TAKHZYRO lanadelumab (rch) 300mg/2mL solution for injection vial, Takeda Pharmaceuticals Australia Pty Ltd, CON-632

7 October 2020

Section 14 consent

Consent to while noncompliant with standards.